HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Other Working Capital Changes (2018 - 2021)

HUTCHMED (China)'s (HMDCF) quarterly Other Working Capital Changes came in at -$3.9 million in Q2 2021, down 214.23% year-over-year from $3.4 million in Q2 2020, and down 367.96% quarter-over-quarter from $1.5 million in Q1 2021.

Analysis

HUTCHMED (China) (HMDCF) Other Working Capital Changes (2018 - 2021) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Other Working Capital Changes for 4 consecutive years, with -$3.9 million the latest figure, recorded in Q2 2021.

  • On a quarterly basis, Other Working Capital Changes fell 214.23% year-over-year to -$3.9 million in Q2 2021; TTM through Jun 2021 was -$3.2 million, a 25.35% decrease from a year earlier, with the FY2025 full-year figure at -$49.6 million, down 90.88% from the prior year.
  • Other Working Capital Changes was -$3.9 million for Q2 2021 at HUTCHMED (China), down from $1.5 million in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $27.3 million in Q4 2019 and troughed at -$17.5 million in Q2 2021.
  • A 4-year average of $559916.7 and a median of -$918000.0 in 2019 frame the typical range for Other Working Capital Changes.
  • The widest YoY moves for Other Working Capital Changes: up 187.08% in 2021, down 214.23% in 2021.
  • Over 4 years, Other Working Capital Changes stood at -$2.0 million in 2018, then tumbled by 46.67% to -$2.9 million in 2019, then surged by 56.59% to -$1.3 million in 2020, then tumbled by 214.23% to -$3.9 million in 2021.
  • The last three Other Working Capital Changes figures came in at -$3.9 million (Q2 2021), $1.5 million (Q1 2021), and -$1.3 million (Q2 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 212.20 Bn 198.21 Bn 7.24 Bn
2 Gilead Sciences 181.83 Bn 178.65 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.47 Bn 124.61 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.56 Bn 74.56 Bn 3.93 Bn
5 Argenx Se 61.59 Bn 56.40 Bn 1.37 Bn
6 Moderna 54.65 Bn 49.51 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.13 Bn 30.82 Bn 992.69 Mn
8 Biogen 31.42 Bn 30.13 Bn 1.96 Bn
9 Roivant Sciences 30.21 Bn 30.21 Bn 1.16 Mn
10 HUTCHMED (China) 376.85 Mn 391.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -3.93 Mn
Jun 30, 2021 -3.93 Mn
Mar 31, 2021 1.47 Mn
Mar 31, 2021 1.47 Mn
Jun 30, 2020 -1.25 Mn
Jun 30, 2020 -1.25 Mn
Mar 31, 2020 511,000.00
Mar 31, 2020 511,000.00
Dec 31, 2019 -2.88 Mn
Dec 31, 2019 -2.88 Mn
Sep 30, 2019 1.07 Mn
Sep 30, 2019 1.07 Mn
Jun 30, 2019 -733,000.00
Jun 30, 2019 -733,000.00
Mar 31, 2019 1.84 Mn
Mar 31, 2019 1.84 Mn
Dec 31, 2018 -1.97 Mn
Dec 31, 2018 -1.97 Mn
Sep 30, 2018 736,000.00
Sep 30, 2018 736,000.00